Grayscale Horizen Trust (Zen) is a US-based company operating in industry. The company is headquartered in Stamford, Connecticut. The company went IPO on 2021-10-18. Grayscale Horizen Trust is a Delaware Statutory Trust (the Trust). The Trust solely invested in and deriving value from the price of Horizen (ZEN) that enables investors to gain exposure to ZEN in the form of a security while avoiding the challenges of buying, storing, and safekeeping ZEN, directly. The Horizen Network allows people to exchange tokens of value, called ZEN, which are recorded on a public transaction ledger known as a blockchain. The Trust's investment activities are limited to issuing Baskets in exchange for ZEN transferred to the Trust as consideration in connection with the creations; transferring or selling ZEN, Incidental Rights and IR Virtual Currency as necessary to cover the Sponsor’s Fee and/or any Additional Trust Expenses; making distributions of Incidental Rights and/or IR Virtual Currency or cash from the sale thereof, and others. The Trust’s Sponsor is Grayscale Investments, LLC.
Jazz Pharmaceuticals PLC 的流動比率為 0,淨利潤率為 0,每股銷售為 $0。
Grayscale Horizen Trust (Zen) 的收入按細分市場或地理位置如何劃分?
Jazz Pharmaceuticals PLC 最大收入來源為 Pharmaceutical Products,在最近的收益報告中收入為 4,068,950,000。就地區而言,United States 是 Jazz Pharmaceuticals PLC 的主要市場,收入為 3,660,109,000。